Company charts expanded direction and names new key additions
| BOSTON, Oct. 8, 2018 /PRNewswire/ -- Atlas Genetics, a pioneer in near-patient testing solutions, has been renamed Binx Health, and has aligned with additional healthcare pioneers as it redefines new categories of convenient testing where people live, work and shop.
“Reaching tens of millions of people globally with convenient solutions for routine care, requires evidence-based tools in digital health and rapid-PCR desktop instruments,” said Jeffrey Luber, Chief Executive Officer of Binx Health. “According to the CDC, rates of sexually-transmitted infections (STIs) continue to rise, underscoring the need for better answers. At Binx Health, we intend to redefine care with world-class practitioners at our side and a mission to bring appropriately tailored and clinically-supported answers to millions. Today is an important milestone in our journey, and we could not be more excited for what comes next.” The Company’s proprietary desktop point-of-care platform is designed to perform rapid and accurate PCR detection and provide a result in about 30 minutes. The platform is currently in a clinical study to obtain FDA clearance for chlamydia and gonorrhea, among the most prevalent STIs globally. The Company is also launching mobile and digital solutions for at-home testing in order to broaden patient access under the guidance of licensed physicians for thoughtful and responsible care delivery. Together, the Company’s point-of-care and digital health offerings will meet people where testing is most convenient for them whether at home, in the supermarket, at their retail pharmacy, or at a wellness fair at work. The Company has also added industry pioneers and medical leaders in new roles on the Binx Health team. Additions “Stan’s ideas and inventions have given birth to some of our industry’s biggest successes and have changed the lives of millions,” said Luber. “He cares deeply about bringing essential care to broad populations through new delivery methods and to ensuring the highest integrity at every step of the process. His guidance and strategic vision will be central to our growth and continued expansion.” Chief Medical Officer “I am excited to join the Binx team as Chief Medical Officer as we aim to revolutionize access to routine testing, starting with STIs. Improving the accessibility and convenience of evidence-based, clinically relevant testing will lead to more people getting screened and getting screened sooner in a responsible and medically-appropriate way,” said Heller. “Since the early treatment of asymptomatic persons is the most effective way to prevent transmission of STIs to others, the potential impact on public health through Binx Health’s multiple platforms, in multiple important channels, is a significant advance in public health.” Director of Medical Affairs “Too often, tests are sold to people without appropriate context or direction, particularly online,” said Dr. Higham. “I was drawn to Binx because of the unique promise of their point-of-care platform and also for the company’s unique commitment to evidence-based care whether in digital health or more traditional environments. I’m excited by the opportunity to contribute to the Binx product suite and to help improve care for so many.” About Binx Health Contact: Brian Heffron, bheffron@ctpboston.com, 781.799.9568
SOURCE Binx Health |
View original content to download multimedia:
